Clinical Trials Directory

Trials / Unknown

UnknownNCT03577964

Development of Pneumonia Due to Alveolar Glucose Levels in Systemic Hyperglycemia

Status
Unknown
Phase
Study type
Observational
Enrollment
61 (actual)
Sponsor
University of Ulm · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Incidence of Pneumonia in Patients with high systemic glucose levels.

Detailed description

Clinical and mechanistic studies have shown that a hyperglycaemic metabolic condition is associated with a higher incidence of infection and consecutive increased morbidity and mortality. The underlying mechanisms in detail are not completely understood. So far it is not clear whether systemic increased glucose levels are caused by a stress reaction of the body through a catabolic metabolism situation as well as a "stress-induced insulin resistance", or infections are promoted by hyperglycemia. From in vivo and in vitro studies, a glucose threshold for the lung is known (147 mg / dL), similar to that in the kidney. It can be hypothesized, that an intra-alveolar glucose in turn promotes bacterial growth as a nutrient substrate. The aim of the study is to determine the concentration of glucose in the alveolar space in connection with hyperglycemic conditions, and to demonstrate a higher incidence of pneumonia in this patient group. The study will enroll cardiac surgery patients receiving surgical treatment and expected postoperative ventilation. Systemic blood glucose monitoring is recorded throughout hospitalization, as well as the removal of bronchial aspirates intraoperatively and during ventilation to measure glucose levels and bacterial levels. The incidence of pneumonia is recorded during the postoperative period by means of radiological examinations and / or microbiological examinations.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTGlucose Measurements,Measurement of glucose Levels in bronchio alveolar secretions

Timeline

Start date
2017-09-01
Primary completion
2019-04-25
Completion
2020-04-25
First posted
2018-07-05
Last updated
2019-04-26

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03577964. Inclusion in this directory is not an endorsement.